- Home
- MNPR vs API Comparison
MNPR vs API Comparison
Compare MNPR & API Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MNPR | API |
|---|---|---|
| Founded | 2014 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 421.0M | 386.2M |
| IPO Year | 2019 | 2020 |
Fundamental Metrics
Financial Performance| Metric | MNPR | API |
|---|---|---|
| Price | $58.89 | $4.57 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 13 | 0 |
| Target Price | ★ $101.42 | N/A |
| AVG Volume (30 Days) | 220.8K | ★ 393.6K |
| Earning Date | 02-25-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $7.21 |
| Revenue Next Year | N/A | $12.30 |
| P/E Ratio | ★ N/A | $92.30 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $26.06 | $2.53 |
| 52 Week High | $105.00 | $6.99 |
Technical Indicators
Market Signals| Indicator | MNPR | API |
|---|---|---|
| Relative Strength Index (RSI) | 42.30 | 53.35 |
| Support Level | $56.15 | $3.40 |
| Resistance Level | $61.30 | $4.67 |
| Average True Range (ATR) | 3.99 | 0.23 |
| MACD | -0.11 | 0.01 |
| Stochastic Oscillator | 39.19 | 45.92 |
Price Performance
Historical ComparisonAbout MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
About API Agora Inc.
Agora Inc provides real-time communication solutions. The company offers real-time video calling, voice calling, live audio and video streaming, recording, and real-time messaging. It serves the gaming, retail, and education industries. The company operates in the People's Republic of China and the United States of America and the majority of its revenue is derived from the People's Republic of China.